Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease.

Wamkpah, Nneoma; Shrestha, Anuj; Salzman, Gary; Simon, Stephen; Suman, Sahil; Poisner, Alan; Molteni, Agostino

Wamkpah, Nneoma; Shrestha, Anuj; Salzman, Gary; Simon, Stephen; Suman, Sahil; Poisner, Alan; Molteni, Agostino.

Afiliação

Wamkpah N; Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, Saint Louis, USA.
Shrestha A; Hematology and Oncology, University of Missouri-Kansas City, Kansas City, USA.
Salzman G; Internal Medicine, University of Missouri-Kansas City, Kansas City, USA.
Simon S; Bioinformatics, University of Missouri-Kansas City, Kansas City, USA.
Suman S; Bioinformatics, University of Missouri-Kansas City, Kansas City, USA.
Poisner A; Pharmacology, University of Missouri-Kansas City, Kansas City, USA.
Molteni A; Pathology, University of Missouri-Kansas City, Kansas City, USA.

Cureus ; 14(3): e23567, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35494947

Palavras-chave

acute chest syndrome (acs); angiotensin converting enzyme inhibitors (acei); angiotensin ii receptor blockers (arb); pulmonary fat embolism (pfe); sick sickle cell disease (scd)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google